Dr. Reddy's Laboratories arrives at its June 5 earnings release carrying the same stubborn split that has defined this entire preview cycle — though the data has shifted under both camps since yesterday's article.
The short side has eased at the margin but remains entrenched near cycle highs. Shares short dipped fractionally to 19.65 million on June 2, down less than 0.3% on the day, and the one-month build remains a steep 44%. The ORTEX short score held at 57.0, essentially unchanged from yesterday and still well above the mid-50s readings that characterised early May. Availability ticked down slightly to 59.9% from 60.9% in yesterday's preview — still within the recovered range, but a genuine distance from the 31–33% cycle lows of the week of May 18–22. Cost to borrow jumped sharply, moving from 0.77% to 1.07% overnight — the highest rate of the entire preview cycle, and up 77% over the past month. That borrow spike is the freshest signal: it suggests renewed short demand is pressing against a lending pool that, while looser than its tightest point, is absorbing pressure again ahead of the print.
Options traders have not moved. The put/call ratio edged to 0.15 on June 3, barely distinguishable from the 0.14–0.15 range that has anchored flow since mid-May. That reading runs well below the 20-day average of 0.42, placing it near the call-heavy extreme of the past year. The options market's message has been consistent throughout this cycle: participants on that side are positioned for upside, not protection. The divide between the two camps — short sellers building at cycle highs, options flow tilted bullishly — is as wide now as it was when this series of previews began.
Valuation offers a middle ground of sorts. The P/E has compressed to 21.7x, down roughly one full turn over the past month, while EV/EBITDA sits near 13.2x. The earnings yield has crept upward, approaching 4.6% — a modest improvement in the stock's relative cheapness as the price has slipped 5% over the past month to $13.02. The dividend score ranks in the 90th percentile, reflecting the company's consistent payout history, but the EPS surprise rank of just the 11th percentile signals that beats have been scarce.
Tomorrow's print is the first opportunity to resolve whether the short sellers who built aggressively through May — or the options market that ignored them entirely — read the quarter correctly.
See the live data behind this article on ORTEX.
Open RDY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
